Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Gland Pharma Ltd

NSE: GLAND · BSE: 543245 · Pharmaceuticals & Biotechnology · 47 announcements

Gland Pharma Ltd news stories on ALFA NewsRead the news →
Share price
₹3,006.10
Market cap
₹49,604 Cr
Revenue (annual)
₹6,431 Cr
Net profit (annual)
₹1,027 Cr
P/E (TTM)
43.9×Sector 47.4×
Promoter holding
51.77%-0.06% QoQ
FII holding
8.74%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 7Management Change 6Earnings Call 6Employee Stock Options 4Board Meeting Outcome 4Other Announcement 3Legal & Regulatory 3Business Update 3Financial Results 2Results Update 1Promoter Selling 1Product Launch 1New Order Win 1Merger & Restructuring 1Capital Structure Change 1Capacity Expansion 1Board Meeting Date 1Acquisition 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

1 announcement with these filters

16:27 IST NSE
Acquisition

Gland Pharma Acquisition Worth ₹4.76 Cr

Gland Pharma approved acquiring its step-down subsidiary, Gland Pharma USA Inc., from another wholly-owned subsidiary to streamline corporate structure. The transaction costs USD 5,01,208.

Value
₹4.76 Cr
Execution
By October 31, 2026
Read the filing ↗